Ischemic Stroke and Cancer: Stroke Severely Impacts Cancer Patients, While Cancer Increases the Number of Strokes
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
BackgroundzzCancer and ischemic stroke are two of the most common causes of death among the elderly, and associations between them have been reported. However, the main pathomechanisms of stroke in cancer patients are not well known, and can only be established based on accurate knowledge of the characteristics of cancer-related strokes. We review herein recent studies concerning the clinical, laboratory, and radiological features of patients with cancer-related stroke. Main ContentszzThis review covers the epidemiology, underlying mechanisms, and acute and preventive treatments for cancer-related stroke. First, the characteristics of stroke (clinical and radiological features) and systemic cancer (type and extent) in patients with cancer-specific stroke are discussed. Second, the role of laboratory tests in the early identification of patients with cancer-specific stroke is discussed. Specifically, serum D-dimer levels (as a marker of a hypercoagulable state) and embolic signals on transcranial Doppler (suggestive of embolic origin) may provide clues regarding changes in the levels of coagulopathy related to cancer and anticoagulation. Finally, strategies for stroke treatment in cancer patients are discussed, emphasizing the importance of preventive strategies (i.e., the use of anticoagulants) over acute revascularization therapy in cancer-related stroke. ConclusionzzRecent studies have revealed that the characteristics of cancer-related stroke are distinct from those of conventional stroke. Our understanding of the characteristics of cancer-related stroke is essential to the correct management of these patients. The studies presented in this review highlight the importance of a personalized approach in treating stroke patients with cancer.
Abstract
BackgroundzzCancer and ischemic stroke are two of the most common causes of death among the elderly, and associations between them have been reported. However, the main pathomechanisms of stroke in cancer patients are not well known, and can only be established based on accurate knowledge of the characteristics of cancer-related strokes. We review herein recent studies concerning the clinical, laboratory, and radiological features of patients with cancer-related stroke. Main ContentszzThis review covers the epidemiology, underlying mechanisms, and acute and preventive treatments for cancer-related stroke. First, the characteristics of stroke (clinical and radiological features) and systemic cancer (type and extent) in patients with cancer-specific stroke are discussed. Second, the role of laboratory tests in the early identification of patients with cancer-specific stroke is discussed. Specifically, serum D-dimer levels (as a marker of a hypercoagulable state) and embolic signals on transcranial Doppler (suggestive of embolic origin) may provide clues regarding changes in the levels of coagulopathy related to cancer and anticoagulation. Finally, strategies for stroke treatment in cancer patients are discussed, emphasizing the importance of preventive strategies (i.e., the use of anticoagulants) over acute revascularization therapy in cancer-related stroke. ConclusionzzRecent studies have revealed that the characteristics of cancer-related stroke are distinct from those of conventional stroke. Our understanding of the characteristics of cancer-related stroke is essential to the correct management of these patients. The studies presented in this review highlight the importance of a personalized approach in treating stroke patients with cancer.
참고문헌 (33)
- Graus F, "Cerebrovascular complications in patients with cancer", Medicine (Baltimore), 64, pp.16~35 (1985)
- Bick RL, "Cancer-associated thrombosis", N Engl J Med, 349, pp.109~111 (2003)
- Rogers LR, "Cerebrovascular complications in patients with cancer", Semin Neurol, 24, pp.453~460 (2004)
- Grisold W, "Stroke and cancer: a review", Acta Neurol Scand, 119, pp.1~16 (2009)
- Kim SG, "Ischemic Stroke in Cancer Patients With and Without Conventional Mechanisms A Multicenter Study in Korea", STROKE, 41, pp.798~801, LIPPINCOTT WILLIAMS & WILKINS
- Chaturvedi S, "Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability", Stroke, 25, pp.1215~1218 (1994)
- Zhang YY, "Stroke risk factor, pattern and outcome in patients with cancer", Acta Neurol Scand, 114, pp.378~383 (2006)
- Zhang YY, "Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study", Cerebrovasc Dis, 23, pp.181~187 (2007)
- Cestari DM, "Stroke in patients with cancer: incidence and etiology", Neurology, 62, pp.2025~2030 (2004)
- Baird AE, "Multiple acute stroke syndrome: marker of embolic disease", Neurology, 54, pp.674~678 (2000)
- Bang OY, "Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory", Neurol Neurosurg Psychiatry, 76, pp.1222~1228 (2005)
- Kwon HM, "Stroke as the first manifestation of concealed cancer", J Neurol Sci, 258, pp.80~83 (2007)
- ten Wolde M, "The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis", Arch Intern Med, 162, pp.1880~1884 (2002)
- Seok JM, "Coagulopathy and Embolic Signal in Cancer Patients with Ischemic Stroke", ANNALS OF NEUROLOGY, 68, pp.213~219, WILEY-LISS
- Dirix LY, "Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer", Br J Cancer, 86, pp.389~395 (2002)
- Buccheri G, "Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance", Cancer, 97, pp.3044~3052 (2003)
- Blackwell K, "Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma", Cancer, 101, pp.77~82 (2004)
- Poppert H, "Embolic signals in unselected stroke patients: prevalence and diagnostic benefit", Stroke, 37, pp.2039~2043 (2006)
- Singhal AB, "Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusionweighted magnetic resonance imaging study", Stroke, 33, pp.1267~1273 (2002)
- Rickles FR, "Tissue factor, thrombin, and cancer", Chest, 124, pp.58~68 (2003)
- Li SH, "Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients", Clin Neurol Neurosurg, 108, pp.150~156 (2006)
- Ratajczak J, "Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication", Leukemia, 20, pp.1487~1495 (2006)
- Mostefai HA, "Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer", Physiol Res, 57, pp.311~320 (2008)
- Yu JL, "Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis", Blood, 105, pp.1734~1741 (2005)
- Hron G, "Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer", Thromb Haemost, 97, pp.119~123 (2007)
- Yu JL, "Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells", J Thromb Haemost, 2, pp.2065~2067 (2004)
- 방오영, "Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies", Journal of Clinical Neurology, 5(3), pp.107~119 (2009), 대한신경과학회
- Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)
- Varki A, "Trousseau’s syndrome: multiple definitions and multiple mechanisms", Blood, 110, pp.1723~1729 (2007)
- Sousou T, "New insights into cancer-associated thrombosis", Arterioscler Thromb Vasc Biol, 29, pp.316~320 (2009)
- Carrier M, "Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology", Nat Clin Pract Oncol, 6, pp.74~84 (2009)
- Lee AY, "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer", N Engl J Med, 349, pp.146~153 (2003)
- Agnelli G, "Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study", Lancet Oncol, 10, pp.943~949 (2009)